Transforming HIV Diagnosis: A Low-Cost, Point-of-Care Detection Solution | Newswise

Transforming HIV Diagnosis: A Low-Cost, Point-of-Care Detection Solution | Newswise

Newswise — Human immunodeficiency virus (HIV) remains a global health challenge, with millions of people affected worldwide. Early diagnosis is essential for timely antiretroviral therapy and preventing transmission. However, current nucleic acid tests (NATs) often require advanced laboratory infrastructure and trained personnel, making them impractical in low-resource settings. While antibody-based rapid tests provide convenience, they…

Read More
Aptitude Secures M+ to Accelerate Development o | Newswise

Aptitude Secures $10M+ to Accelerate Development o | Newswise

Newswise — SANTA BARBARA, Calif., Jan. 6, 2025 — Aptitude Medical Systems, Inc. (Aptitude) has secured funding from the Bill & Melinda Gates Foundation to accelerate the development and release of its new Point of Care (POC) and Over-The-Counter (OTC) Chlamydia, gonorrhea, and trichomoniasis sexually transmitted infection (STI) test on the Metrix® molecular diagnostics platform. The…

Read More
How HIV Research Reshaped Modern Medicine | Newswise

How HIV Research Reshaped Modern Medicine | Newswise

Newswise — In 1981, fresh out of medical school, physician-scientist Bruce Walker began his internship at Massachusetts General Hospital. One day, a young patient showed up with an unusual cluster of infections and cancers. Baffled and powerless to treat him, Walker and his colleagues could only watch as the patient quickly succumbed to the mysterious…

Read More